Literature DB >> 8437088

Renal transplantation for infantile cystinosis: long-term follow-up.

P S Almond1, A J Matas, R E Nakhleh, P Morel, C Troppmann, J S Najarian, B Chavers.   

Abstract

Renal transplantation for infantile cystinosis corrects renal failure and prolongs survival. However, after transplantation, the disease may develop in the allograft and continue to progress in nonrenal organs. We studied seven children (6 boys, 1 girl) with infantile cystinosis who received 11 renal transplants (3 cadaver, 8 living-related) between May 1969 and December 1986. The age at transplant ranged from 6 to 12 years (mean, 9.1 years). Four children received second renal transplants at a mean age of 17 years (range, 16 to 22 years). The mean period of follow-up was 138 +/- 47 months. Three children received cysteamine therapy prior to transplantation. Nonrenal complications of infantile cystinosis present before transplantation were photophobia (n = 3), corneal crystals (n = 5), hypothyroidism (n = 1), rickets (n = 6), and short stature (n = 7). Graft and patient survival did not differ from controls matched for the time of transplantation. Two patients died (1 pneumococcal sepsis, 1 respiratory failure due to pulmonary fibrosis) with functioning grafts 5 and 14 years posttransplant. Complications that developed posttransplant included photophobia (n = 1), corneal crystals (n = 2), hypothyroidism (n = 4), polyneuropathy (n = 1), pulmonary fibrosis (n = 1), abnormal electroencephalogram without clinical seizures (n = 1), bladder stones (n = 1), and diabetes mellitus (n = 2). One patient received a corneal transplant. All seven children failed to show improvement in growth following transplantation. Cystine crystals are present in graft-infiltrating cells, but do not seem to affect kidney allograft function.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8437088     DOI: 10.1016/s0022-3468(05)80282-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

Review 1.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

Review 2.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.

Authors:  Ekaterini Tsilou; Min Zhou; William Gahl; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

3.  Renal allograft survival according to primary diagnosis: a report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  C E Kashtan; P T McEnery; A Tejani; D M Stablein
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

Review 4.  Nephropathic cystinosis: late complications of a multisystemic disease.

Authors:  Galina Nesterova; William Gahl
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

5.  Hypercalciuria and ultrasound abnormalities in children with cystinosis.

Authors:  M A Saleem; D V Milford; H Alton; S Chapman; M H Winterborn
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

6.  Structured Transition Protocol for Children with Cystinosis.

Authors:  Rupesh Raina; Joseph Wang; Vinod Krishnappa
Journal:  Front Pediatr       Date:  2017-08-31       Impact factor: 3.418

Review 7.  Cystinosis: the evolution of a treatable disease.

Authors:  Galina Nesterova; William A Gahl
Journal:  Pediatr Nephrol       Date:  2012-08-18       Impact factor: 3.714

8.  Role of p-glycoprotein expression and function in cystinotic renal proximal tubular cells.

Authors:  Karen Peeters; Martijn J Wilmer; Joost P Schoeber; Dorien Reijnders; Lambertus P van den Heuvel; Rosalinde Masereeuw; Elena Levtchenko
Journal:  Pharmaceutics       Date:  2011-10-27       Impact factor: 6.321

Review 9.  Cysteamine hydrochloride eye drop solution for the treatment of corneal cystine crystal deposits in patients with cystinosis: an evidence-based review.

Authors:  Achini K Makuloluwa; Fatemeh Shams
Journal:  Clin Ophthalmol       Date:  2018-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.